- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Engineering chimeric antigen receptor-T cells for cancer treatment ; volume:17 ; number:1 ; day:15 ; month:2 ; year:2018 ; pages:1-16 ; date:12.2018
Molecular cancer ; 17, Heft 1 (15.2.2018), 1-16, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Ye, Baixin
- Contributor
-
Stary, Creed M.
Li, Xuejun
Gao, Qingping
Kang, Chunsheng
Xiong, Xiaoxing
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0814-0
- URN
-
urn:nbn:de:1111-201804085557
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ye, Baixin
- Stary, Creed M.
- Li, Xuejun
- Gao, Qingping
- Kang, Chunsheng
- Xiong, Xiaoxing
- SpringerLink (Online service)
Other Objects (12)
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy